托吡卡胺
外观
临床资料 | |
---|---|
商品名 | Mydriacyl, others |
AHFS/Drugs.com | Monograph |
核准状况 | |
怀孕分级 |
|
给药途径 | Topical eye drops |
ATC码 | |
法律规范状态 | |
法律规范 |
|
药物动力学数据 | |
血浆蛋白结合率 | 45% |
识别信息 | |
| |
CAS号 | 1508-75-4 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.014.673 |
化学信息 | |
化学式 | C17H20N2O2 |
摩尔质量 | 284.36 g·mol−1 |
3D模型(JSmol) | |
| |
|
托吡卡胺(英语:Tropicamide,商品名:Mydriacyl)是一种含氮有机化合物,化学式C17H20N2O2,是视力测试中促进瞳孔放大的药物[3]。
参考文献
[编辑]- ^ Summary for ARTG Entry: 25356 Mydriacyl tropicamide 0.5% eye drops bottle. Therapeutic Goods Administration. [5 June 2023]. (原始内容存档于5 June 2023).
- ^ Mydriacyl 1% eye drops, solution - Summary of Product Characteristics (SmPC). Electronic Medicines Compendium. 12 February 2020 [29 July 2020]. (原始内容存档于27 June 2022).
- ^ World Health Organization. Stuart MC, Kouimtzi M, Hill SR , 编. WHO Model Formulary 2008. World Health Organization. 2009: 314. ISBN 9789241547659. hdl:10665/44053 .
外部链接
[编辑]- Tropicamide. Drug Information Portal. U.S. National Library of Medicine. [2024-02-12]. (原始内容存档于2021-04-22).